Community post

Mt. Sinai Hospital in NYC is now recruiting patients for a randomized, controlled, double-blind, Phase 1/2a phage therapy trial. The goal: test the safety and efficacy of Intralytix's EcoActive phage collection on intestinal AIEC (adherent invasive E. coli) in Crohn's Disease patients.